Tag: sleeping pills market analysis

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Sleeping Pills Market Size And Revenue Outlook Through 2030

The sleeping pills market has experienced significant expansion in recent years. Projections indicate its size will increase from $85.87 billion in 2025 to $93.03 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.3%. Historically, this growth can be linked to factors such as the restricted accessibility of sleep disorder treatments, a rise in the prevalence of insomnia, the strong presence of prescription sleeping pills, established pharmacy distribution networks, and a general lack of understanding regarding sleep hygiene.

The sleeping pills market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a value of $126.55 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.0%. Key factors contributing to this expansion during the forecast period include the introduction of innovative non-benzodiazepine medications, a growing preference for melatonin and herbal sleep aids, deeper penetration of online pharmacies, tailored sleep treatment initiatives, and an enlarging base of elderly and adult consumers. Significant trends expected in the same period involve a worldwide increase in sleep disorder diagnoses, a higher uptake of over-the-counter sleep solutions, an intensifying emphasis on individualized sleep therapies, the broadening reach of online pharmacies and e-commerce platforms, and heightened awareness regarding natural and herbal sleep supplements.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=86847056&type=smp&name=Sleeping%20Pills%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Sleeping Pills Market Development Factors: What’s Supporting Demand?

The expanding occurrence of mental health conditions is projected to drive the growth of the sleeping pills market in the future. Mental illness encompasses various psychological states that impact an individual’s mood, thought processes, conduct, and general functionality. The rise in mental illness can be attributed to heightened chronic stress, given that extended stress interferes with brain activity and either initiates or exacerbates mental health issues. Sleeping pills assist in addressing mental illness by enhancing sleep quality, a crucial factor for maintaining emotional and cognitive balance. These medications contribute to alleviating anxiety and depression symptoms by facilitating restorative sleep, thereby improving overall mental well-being and daily performance. For example, data from 2025, provided by US-based health agencies National Alliance on Mental Illness and NextStep Solutions Behavioral Health, indicated that the prevalence of serious mental illness (SMI) was approximately 5.44% among adults in 2023 and stayed nearly consistent at about 5.6% in 2024, demonstrating steadiness within this severe category. Consequently, the growing incidence of mental illness is a primary factor propelling the expansion of the sleeping pills market.

Sleeping Pills Market Breakdown By Product Type And Application

The sleeping pills market covered in this report is segmented –

1) By Medication Type: Prescription Sleeping Pills, Over The Counter (OTC) Sleeping Pills

2) By Product Type: Benzodiazepines, Non Benzodiazepines

3) By Sleep Disorder: Insomnia, Sleep Disorder, Restless Leg Syndrome Narcolepsy, Sleepwalking

4) By Consumer Demographics: Age Groups, Gender, Health Conditions

5) By Distribution Channel: Retail Pharmacies, Online Pharmacies, Hospitals And Clinics, Health And Wellness Stores

Subsegments:

1) By Prescription Sleeping Pills: Benzodiazepines, Non-Benzodiazepines, Antidepressants, Antihistamines, Melatonin Receptor Agonists, Orexin Receptor Antagonists

2) By Over The Counter (OTC): Diphenhydramine, Doxylamine, Melatonin Supplements, Valerian Root

Sleeping Pills Market Transformation Trends: What Innovations Are Driving Change?

Companies operating within the sleeping pills market are concentrating on developing advanced formulations, such as innovative drug compositions, to improve sleep quality, reduce dependency risks, and minimize side effects. Novel drug formulations entail the creation of new medication compositions designed to enhance efficacy, boost absorption, decrease adverse reactions, and offer more targeted and patient-friendly treatment options. As an illustration, in October 2024, Neurovalens, a UK-based medical device company, introduced Modius Sleep, a Food and Drug Administration (FDA)-cleared, physician-prescribed medical device intended to treat chronic insomnia in adults aged 22 and older. This device utilizes low-level electrical vestibular nerve stimulation to target the hypothalamus and brainstem, areas responsible for regulating sleep and circadian rhythms. Worn on the head for 30 minutes each evening, typically 1–2 hours before bedtime, its intensity is adjustable for user comfort. Modius Sleep is straightforward to use, portable, and can be worn while engaging in activities such as reading or watching TV.

Sleeping Pills Market Company Landscape And Competitive Strategy

Major companies operating in the sleeping pills market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Eisai Co Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Cipla Limited, Aurobindo Pharma Ltd. , Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Perrigo Company plc, Mallinckrodt Pharmaceuticals plc, Idorsia Pharmaceuticals Ltd, Procter & Gamble Health Limited (P&G Health), Allegiant Health

View The Full Sleeping Pills Market Report:

https://thebusinessresearchcompany.com/report/sleeping-pills-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Sleeping Pills Market Geographic Landscape: Which Region Leads Industry Growth?

North America was the largest region in the sleeping pills market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the sleeping pills market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Sleeping Pills Market Size Outlook: How Fast Will Revenue Grow Through 2030?

The sleeping pills market has experienced robust expansion in recent years, with projections indicating an increase from $85.87 billion in 2025 to $93.03 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.3%. This historical growth has been driven by factors such as the restricted accessibility of sleep disorder therapies, a rising incidence of insomnia, the predominance of prescription-based sleeping aids, reliance on conventional pharmacy distribution networks, and limited public understanding of proper sleep hygiene practices.

The market for sleeping pills is projected to experience robust expansion over the coming years, reaching a value of $126.55 billion by 2030 with a compound annual growth rate (CAGR) of 8.0%. This anticipated growth during the forecast period is driven by factors such as the creation of innovative non-benzodiazepine medications, a growing preference for melatonin and herbal remedies, greater accessibility through online pharmacies, customized sleep management programs, and an expanding base of elderly and adult consumers. Key developments shaping this period include a worldwide increase in sleep disorder cases, a higher uptake of non-prescription sleep aids, a stronger emphasis on tailored sleep therapies, the growth of digital pharmacy and e-commerce platforms, and heightened consumer interest in natural and herbal sleep products.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24704&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Sleeping Pills Market Growth Drivers And Industry Catalysts

The growing occurrence of mental health disorders is anticipated to drive forward the sleeping pills market. Mental illness encompasses various conditions that impact mood, cognition, behavior, and daily life. This rise is linked to elevated chronic stress levels, as sustained stress interferes with brain activity and can initiate or exacerbate mental health issues. Sleeping pills support mental illness management by enhancing sleep quality, crucial for emotional and cognitive stability. They aid in alleviating anxiety and depression symptoms by facilitating restorative sleep and boosting overall mental health and daily performance. For example, in 2025, data from the National Alliance on Mental Illness and NextStep Solutions Behavioral Health, US-based health groups, indicated that serious mental illness prevalence was approximately 5.44% in 2023 and stayed near 5.6% of adults in 2024, showing an unchanged severe category. Thus, the rising incidence of mental illness is fueling growth in the sleeping pills market.

Sleeping Pills Market Segment Landscape And Growth Potential

The sleeping pills market covered in this report is segmented –

1) By Medication Type: Prescription Sleeping Pills, Over The Counter (OTC) Sleeping Pills

2) By Product Type: Benzodiazepines, Non Benzodiazepines

3) By Sleep Disorder: Insomnia, Sleep Disorder, Restless Leg Syndrome Narcolepsy, Sleepwalking

4) By Consumer Demographics: Age Groups, Gender, Health Conditions

5) By Distribution Channel: Retail Pharmacies, Online Pharmacies, Hospitals And Clinics, Health And Wellness Stores

Subsegments:

1) By Prescription Sleeping Pills: Benzodiazepines, Non-Benzodiazepines, Antidepressants, Antihistamines, Melatonin Receptor Agonists, Orexin Receptor Antagonists

2) By Over The Counter (OTC): Diphenhydramine, Doxylamine, Melatonin Supplements, Valerian Root

Sleeping Pills Market Trends Influencing Long-Term Demand

Major players in the sleeping pills market are concentrating on creating cutting-edge formulations, particularly novel drug formulations, aimed at improving sleep quality while lowering the risks of dependency and decreasing adverse effects. Novel drug formulations involve the design of new medication compositions intended to boost efficacy, improve absorption, minimize side effects, and offer more targeted and patient-convenient therapeutic options. As an example, in October 2024, Neurovalens, a medical device company based in the UK, introduced Modius Sleep—a prescribed medical device cleared by the Food and Drug Administration (FDA) for treating chronic insomnia in adults aged 22 and older. This device delivers low-level electrical stimulation to the vestibular nerve, targeting the hypothalamus and brainstem, which are responsible for controlling sleep and circadian rhythms. Users wear the device on their head for a 30-minute session each evening, typically one to two hours prior to bedtime, with adjustable intensity settings to ensure comfort. Modius Sleep is user-friendly, portable, and can be utilized during activities like reading or watching TV.

Sleeping Pills Market Competitive Landscape: Who Are The Leading Companies?

Major companies operating in the sleeping pills market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Eisai Co Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Cipla Limited, Aurobindo Pharma Ltd. , Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Perrigo Company plc, Mallinckrodt Pharmaceuticals plc, Idorsia Pharmaceuticals Ltd, Procter & Gamble Health Limited (P&G Health), Allegiant Health

Access The Complete Sleeping Pills Market Report:

https://www.thebusinessresearchcompany.com/report/sleeping-pills-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Sleeping Pills Market Geographic Distribution And Regional Opportunities

North America was the largest region in the sleeping pills market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the sleeping pills market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Sleeping Pills Market Size Outlook: How Fast Will Revenue Grow Through 2030?

The sleeping pills market has experienced robust expansion in recent years, with projections indicating an increase from $85.87 billion in 2025 to $93.03 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.3%. This historical growth has been driven by factors such as the restricted accessibility of sleep disorder therapies, a rising incidence of insomnia, the predominance of prescription-based sleeping aids, reliance on conventional pharmacy distribution networks, and limited public understanding of proper sleep hygiene practices.

The market for sleeping pills is projected to experience robust expansion over the coming years, reaching a value of $126.55 billion by 2030 with a compound annual growth rate (CAGR) of 8.0%. This anticipated growth during the forecast period is driven by factors such as the creation of innovative non-benzodiazepine medications, a growing preference for melatonin and herbal remedies, greater accessibility through online pharmacies, customized sleep management programs, and an expanding base of elderly and adult consumers. Key developments shaping this period include a worldwide increase in sleep disorder cases, a higher uptake of non-prescription sleep aids, a stronger emphasis on tailored sleep therapies, the growth of digital pharmacy and e-commerce platforms, and heightened consumer interest in natural and herbal sleep products.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24704&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Sleeping Pills Market Growth Drivers And Industry Catalysts

The growing occurrence of mental health disorders is anticipated to drive forward the sleeping pills market. Mental illness encompasses various conditions that impact mood, cognition, behavior, and daily life. This rise is linked to elevated chronic stress levels, as sustained stress interferes with brain activity and can initiate or exacerbate mental health issues. Sleeping pills support mental illness management by enhancing sleep quality, crucial for emotional and cognitive stability. They aid in alleviating anxiety and depression symptoms by facilitating restorative sleep and boosting overall mental health and daily performance. For example, in 2025, data from the National Alliance on Mental Illness and NextStep Solutions Behavioral Health, US-based health groups, indicated that serious mental illness prevalence was approximately 5.44% in 2023 and stayed near 5.6% of adults in 2024, showing an unchanged severe category. Thus, the rising incidence of mental illness is fueling growth in the sleeping pills market.

Sleeping Pills Market Segment Landscape And Growth Potential

The sleeping pills market covered in this report is segmented –

1) By Medication Type: Prescription Sleeping Pills, Over The Counter (OTC) Sleeping Pills

2) By Product Type: Benzodiazepines, Non Benzodiazepines

3) By Sleep Disorder: Insomnia, Sleep Disorder, Restless Leg Syndrome Narcolepsy, Sleepwalking

4) By Consumer Demographics: Age Groups, Gender, Health Conditions

5) By Distribution Channel: Retail Pharmacies, Online Pharmacies, Hospitals And Clinics, Health And Wellness Stores

Subsegments:

1) By Prescription Sleeping Pills: Benzodiazepines, Non-Benzodiazepines, Antidepressants, Antihistamines, Melatonin Receptor Agonists, Orexin Receptor Antagonists

2) By Over The Counter (OTC): Diphenhydramine, Doxylamine, Melatonin Supplements, Valerian Root

Sleeping Pills Market Trends Influencing Long-Term Demand

Major players in the sleeping pills market are concentrating on creating cutting-edge formulations, particularly novel drug formulations, aimed at improving sleep quality while lowering the risks of dependency and decreasing adverse effects. Novel drug formulations involve the design of new medication compositions intended to boost efficacy, improve absorption, minimize side effects, and offer more targeted and patient-convenient therapeutic options. As an example, in October 2024, Neurovalens, a medical device company based in the UK, introduced Modius Sleep—a prescribed medical device cleared by the Food and Drug Administration (FDA) for treating chronic insomnia in adults aged 22 and older. This device delivers low-level electrical stimulation to the vestibular nerve, targeting the hypothalamus and brainstem, which are responsible for controlling sleep and circadian rhythms. Users wear the device on their head for a 30-minute session each evening, typically one to two hours prior to bedtime, with adjustable intensity settings to ensure comfort. Modius Sleep is user-friendly, portable, and can be utilized during activities like reading or watching TV.

Sleeping Pills Market Competitive Landscape: Who Are The Leading Companies?

Major companies operating in the sleeping pills market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Eisai Co Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Cipla Limited, Aurobindo Pharma Ltd. , Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Perrigo Company plc, Mallinckrodt Pharmaceuticals plc, Idorsia Pharmaceuticals Ltd, Procter & Gamble Health Limited (P&G Health), Allegiant Health

Access The Complete Sleeping Pills Market Report:

https://www.thebusinessresearchcompany.com/report/sleeping-pills-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Sleeping Pills Market Geographic Distribution And Regional Opportunities

North America was the largest region in the sleeping pills market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the sleeping pills market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Size Of The Sleeping Pills Market In 2026 And How Much Will It Reach By 2030?

The sleeping pills market has experienced significant expansion in recent years. It is projected to increase from $85.87 billion in 2025 to $93.03 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.3%. This historical growth can be linked to factors such as the limited availability of sleep disorder treatments, the rising occurrence of insomnia, the prevalence of prescription sleeping pills, traditional pharmacy distribution channels, and low awareness about sleep hygiene.

The sleeping pills market is anticipated to experience robust expansion over the coming years. This market is projected to reach $126.55 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.0%. Factors contributing to this growth during the forecast period include the introduction of innovative non-benzodiazepine medications, increased use of melatonin and herbal supplements, greater access through online pharmacies, customized sleep treatment solutions, and a growing consumer base among the elderly and adults. Key trends anticipated during this period encompass a global increase in sleep disorder diagnoses, higher uptake of non-prescription sleep aids, an intensifying emphasis on tailored sleep therapy, the broadening reach of online pharmacies and e-commerce platforms, and heightened understanding of natural and herbal sleep aids.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24704&type=smp

What Market Drivers Are Helping Shape The Sleeping Pills Market Expansion?

The rising occurrence of mental illness is anticipated to stimulate the expansion of the sleeping pills market in the future. Mental illness encompasses various psychological conditions impacting an individual’s mood, thoughts, actions, and general functioning. The spread of mental illness is escalating because of heightened chronic stress, which, when prolonged, impairs brain function and precipitates or aggravates mental health conditions. Sleeping pills assist in addressing mental illness by enhancing sleep quality, a crucial factor for emotional and cognitive balance. These medications contribute to alleviating anxiety and depression symptoms through encouraging restorative sleep and fostering improved mental well-being and daily performance. For example, reports from US-based health agencies, the National Alliance on Mental Illness and NextStep Solutions Behavioral Health, indicated that in 2025, the prevalence of serious mental illness (SMI) stood at approximately 5.44% in 2023, staying near 5.6% of adults in 2024, demonstrating consistency within this severe classification. Consequently, the growing incidence of mental illness is fueling the expansion of the sleeping pills market.

What Segment Types Are Included In The Sleeping Pills Market Analysis?

The sleeping pills market covered in this report is segmented –

1) By Medication Type: Prescription Sleeping Pills, Over The Counter (OTC) Sleeping Pills

2) By Product Type: Benzodiazepines, Non Benzodiazepines

3) By Sleep Disorder: Insomnia, Sleep Disorder, Restless Leg Syndrome Narcolepsy, Sleepwalking

4) By Consumer Demographics: Age Groups, Gender, Health Conditions

5) By Distribution Channel: Retail Pharmacies, Online Pharmacies, Hospitals And Clinics, Health And Wellness Stores

Subsegments:

1) By Prescription Sleeping Pills: Benzodiazepines, Non-Benzodiazepines, Antidepressants, Antihistamines, Melatonin Receptor Agonists, Orexin Receptor Antagonists

2) By Over The Counter (OTC): Diphenhydramine, Doxylamine, Melatonin Supplements, Valerian Root

Which Trends Are Influencing The Expansion Of The Sleeping Pills Market?

Major companies operating in the sleeping pills market are focusing on developing advanced formulations, such as novel drug compositions, to enhance sleep quality, minimize dependency risks, and reduce side effects. Novel drug formulations involve the creation of new medication compositions intended to improve efficacy, enhance absorption, lessen side effects, and offer more targeted and patient-friendly treatment options. For instance, in October 2024, Neurovalens, a UK-based medical device company, launched Modius Sleep, a Food and Drug Administration (FDA)-cleared, physician-prescribed medical device designed to treat chronic insomnia in adults aged 22 and older. It utilizes low-level electrical vestibular nerve stimulation to target the hypothalamus and brainstem, areas that regulate sleep and circadian rhythms. The device is worn on the head for 30 minutes each evening, typically 1–2 hours before bedtime, with adjustable intensity for user comfort. Modius Sleep is easy to use, portable, and can be worn during activities such as reading or watching TV.

Which Companies Form The Competitive Landscape Of The Sleeping Pills Market?

Major companies operating in the sleeping pills market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Eisai Co Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Cipla Limited, Aurobindo Pharma Ltd. , Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Perrigo Company plc, Mallinckrodt Pharmaceuticals plc, Idorsia Pharmaceuticals Ltd, Procter & Gamble Health Limited (P&G Health), Allegiant Health

Access The Complete Sleeping Pills Market Report:

https://www.thebusinessresearchcompany.com/report/sleeping-pills-global-market-report

Which Region Leads The Sleeping Pills Market By Size?

North America was the largest region in the sleeping pills market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the sleeping pills market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Sleeping Pills Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24704&type=smp

Browse Through More Reports Similar to the Global Sleeping Pills Market 2026, By The Business Research Company

Sleep Apnea Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleep-apnea-devices-global-market-report

Sleep Tech Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleep-tech-devices-global-market-report

Sleeping Aids Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleeping-aids-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Sleeping Pills Market In 2026, And How Will Its Value Evolve By 2030?

The sleeping pills market size has seen robust growth over recent years. It is anticipated to expand from $85.87 billion in 2025 to $93.03 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.3%. This historical growth can be linked to the limited availability of sleep disorder treatments, an increasing prevalence of insomnia, the strong presence of prescription sleeping pills, established pharmacy distribution channels, and insufficient awareness regarding sleep hygiene.

The sleeping pills market is projected to experience substantial expansion over the upcoming years. By 2030, this market is anticipated to reach a valuation of $126.55 billion, exhibiting a compound annual growth rate (CAGR) of 8.0%. This projected growth during the forecast period stems from factors such as the advancement of new non-benzodiazepine medications, a growing preference for melatonin and herbal supplements, increasing prevalence of online pharmacies, tailored sleep treatment initiatives, and a broadening consumer base among the elderly and adults. Key trends observed within the forecast period encompass a global increase in sleep disorder diagnoses, greater uptake of over-the-counter sleep solutions, an enhanced emphasis on customized sleep therapy, the proliferation of online pharmacies and e-commerce platforms, and heightened awareness regarding natural and herbal sleep aids.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24704&type=smp

What Key Drivers Are Fueling The Growth Of The Sleeping Pills Market?

A rise in mental illness cases is projected to boost the expansion of the sleeping pills market in the future. These conditions encompass various mental health disorders impacting an individual’s mood, cognitive processes, conduct, and general daily operation. The growing occurrence of mental illness stems from elevated chronic stress, which, when prolonged, impairs brain function and can initiate or exacerbate mental health issues. Sleeping pills contribute to addressing mental illness by enhancing sleep quality, a critical factor for maintaining emotional and cognitive balance. These medications assist in alleviating anxiety and depression symptoms through facilitating restorative sleep, thereby improving general mental well-being and daily performance. For example, data reported in 2025 by US-based health agencies, the National Alliance on Mental Illness and NextStep Solutions Behavioral Health, indicated that the prevalence of serious mental illness (SMI) stood at approximately 5.44% in 2023, staying near 5.6% of adults in 2024, demonstrating consistency within this severe classification. Consequently, the expanding incidence of mental illness is stimulating the development of the sleeping pills market.

What Are The Key Segment Divisions In The Sleeping Pills Market Segment Structure?

The sleeping pills market covered in this report is segmented –

1) By Medication Type: Prescription Sleeping Pills, Over The Counter (OTC) Sleeping Pills

2) By Product Type: Benzodiazepines, Non Benzodiazepines

3) By Sleep Disorder: Insomnia, Sleep Disorder, Restless Leg Syndrome Narcolepsy, Sleepwalking

4) By Consumer Demographics: Age Groups, Gender, Health Conditions

5) By Distribution Channel: Retail Pharmacies, Online Pharmacies, Hospitals And Clinics, Health And Wellness Stores

Subsegments:

1) By Prescription Sleeping Pills: Benzodiazepines, Non-Benzodiazepines, Antidepressants, Antihistamines, Melatonin Receptor Agonists, Orexin Receptor Antagonists

2) By Over The Counter (OTC): Diphenhydramine, Doxylamine, Melatonin Supplements, Valerian Root

Which Trends Are Impacting The Progress Of The Sleeping Pills Market?

Leading companies in the sleeping pills market are concentrating on creating advanced formulations, including novel drug compositions, to improve sleep quality, minimize dependency risks, and reduce side effects. Novel drug formulations entail the development of new medication mixtures intended to enhance effectiveness, optimize absorption, lessen adverse reactions, and deliver more targeted and patient-friendly treatment solutions. For example, in October 2024, Neurovalens, a medical device company based in the UK, introduced Modius Sleep, a Food and Drug Administration (FDA)-cleared, physician-prescribed medical device specifically designed to address chronic insomnia in adults aged 22 and above. This device utilizes low-level electrical vestibular nerve stimulation to target the hypothalamus and brainstem, which are critical areas governing sleep and circadian rhythms. The device is worn on the head for 30 minutes every evening, typically 1–2 hours prior to bedtime, offering adjustable intensity for user comfort. Modius Sleep is user-friendly, portable, and can be worn while engaging in activities such as reading or watching TV.

Which Organizations Are Engaged In The Sleeping Pills Market?

Major companies operating in the sleeping pills market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Eisai Co Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Cipla Limited, Aurobindo Pharma Ltd. , Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Perrigo Company plc, Mallinckrodt Pharmaceuticals plc, Idorsia Pharmaceuticals Ltd, Procter & Gamble Health Limited (P&G Health), Allegiant Health

Get The Full Sleeping Pills Market Report:

https://www.thebusinessresearchcompany.com/report/sleeping-pills-global-market-report

Which Geographic Region Dominates The Sleeping Pills Market?

North America was the largest region in the sleeping pills market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the sleeping pills market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Sleeping Pills Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/sleeping-pills-global-market-report

Browse Through More Reports Similar to the Global Sleeping Pills Market 2026, By The Business Research Company

Sleep Apnea Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleep-apnea-devices-global-market-report

Sleep Tech Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleep-tech-devices-global-market-report

Sleeping Aids Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleeping-aids-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Sleeping Pills Market In 2026, And How Will Its Value Evolve By 2030?

The sleeping pills market size has seen robust growth over recent years. It is anticipated to expand from $85.87 billion in 2025 to $93.03 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.3%. This historical growth can be linked to the limited availability of sleep disorder treatments, an increasing prevalence of insomnia, the strong presence of prescription sleeping pills, established pharmacy distribution channels, and insufficient awareness regarding sleep hygiene.

The sleeping pills market is projected to experience substantial expansion over the upcoming years. By 2030, this market is anticipated to reach a valuation of $126.55 billion, exhibiting a compound annual growth rate (CAGR) of 8.0%. This projected growth during the forecast period stems from factors such as the advancement of new non-benzodiazepine medications, a growing preference for melatonin and herbal supplements, increasing prevalence of online pharmacies, tailored sleep treatment initiatives, and a broadening consumer base among the elderly and adults. Key trends observed within the forecast period encompass a global increase in sleep disorder diagnoses, greater uptake of over-the-counter sleep solutions, an enhanced emphasis on customized sleep therapy, the proliferation of online pharmacies and e-commerce platforms, and heightened awareness regarding natural and herbal sleep aids.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24704&type=smp

What Key Drivers Are Fueling The Growth Of The Sleeping Pills Market?

A rise in mental illness cases is projected to boost the expansion of the sleeping pills market in the future. These conditions encompass various mental health disorders impacting an individual’s mood, cognitive processes, conduct, and general daily operation. The growing occurrence of mental illness stems from elevated chronic stress, which, when prolonged, impairs brain function and can initiate or exacerbate mental health issues. Sleeping pills contribute to addressing mental illness by enhancing sleep quality, a critical factor for maintaining emotional and cognitive balance. These medications assist in alleviating anxiety and depression symptoms through facilitating restorative sleep, thereby improving general mental well-being and daily performance. For example, data reported in 2025 by US-based health agencies, the National Alliance on Mental Illness and NextStep Solutions Behavioral Health, indicated that the prevalence of serious mental illness (SMI) stood at approximately 5.44% in 2023, staying near 5.6% of adults in 2024, demonstrating consistency within this severe classification. Consequently, the expanding incidence of mental illness is stimulating the development of the sleeping pills market.

What Are The Key Segment Divisions In The Sleeping Pills Market Segment Structure?

The sleeping pills market covered in this report is segmented –

1) By Medication Type: Prescription Sleeping Pills, Over The Counter (OTC) Sleeping Pills

2) By Product Type: Benzodiazepines, Non Benzodiazepines

3) By Sleep Disorder: Insomnia, Sleep Disorder, Restless Leg Syndrome Narcolepsy, Sleepwalking

4) By Consumer Demographics: Age Groups, Gender, Health Conditions

5) By Distribution Channel: Retail Pharmacies, Online Pharmacies, Hospitals And Clinics, Health And Wellness Stores

Subsegments:

1) By Prescription Sleeping Pills: Benzodiazepines, Non-Benzodiazepines, Antidepressants, Antihistamines, Melatonin Receptor Agonists, Orexin Receptor Antagonists

2) By Over The Counter (OTC): Diphenhydramine, Doxylamine, Melatonin Supplements, Valerian Root

Which Trends Are Impacting The Progress Of The Sleeping Pills Market?

Leading companies in the sleeping pills market are concentrating on creating advanced formulations, including novel drug compositions, to improve sleep quality, minimize dependency risks, and reduce side effects. Novel drug formulations entail the development of new medication mixtures intended to enhance effectiveness, optimize absorption, lessen adverse reactions, and deliver more targeted and patient-friendly treatment solutions. For example, in October 2024, Neurovalens, a medical device company based in the UK, introduced Modius Sleep, a Food and Drug Administration (FDA)-cleared, physician-prescribed medical device specifically designed to address chronic insomnia in adults aged 22 and above. This device utilizes low-level electrical vestibular nerve stimulation to target the hypothalamus and brainstem, which are critical areas governing sleep and circadian rhythms. The device is worn on the head for 30 minutes every evening, typically 1–2 hours prior to bedtime, offering adjustable intensity for user comfort. Modius Sleep is user-friendly, portable, and can be worn while engaging in activities such as reading or watching TV.

Which Organizations Are Engaged In The Sleeping Pills Market?

Major companies operating in the sleeping pills market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Eisai Co Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Cipla Limited, Aurobindo Pharma Ltd. , Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Perrigo Company plc, Mallinckrodt Pharmaceuticals plc, Idorsia Pharmaceuticals Ltd, Procter & Gamble Health Limited (P&G Health), Allegiant Health

Get The Full Sleeping Pills Market Report:

https://www.thebusinessresearchcompany.com/report/sleeping-pills-global-market-report

Which Geographic Region Dominates The Sleeping Pills Market?

North America was the largest region in the sleeping pills market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the sleeping pills market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Sleeping Pills Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/sleeping-pills-global-market-report

Browse Through More Reports Similar to the Global Sleeping Pills Market 2026, By The Business Research Company

Sleep Apnea Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleep-apnea-devices-global-market-report

Sleep Tech Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleep-tech-devices-global-market-report

Sleeping Aids Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleeping-aids-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Sleeping Pills Market At The End Of The 2026–2030 Forecast Period?

The sleeping pills market has experienced significant expansion in recent years. Its size is anticipated to expand from $85.87 billion in 2025 to $93.03 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.3%. This historical growth can be attributed to several factors, including the restricted availability of sleep disorder treatments, the increasing prevalence of insomnia, the predominant role of prescription sleeping pills, established pharmacy distribution channels, and insufficient knowledge about sleep hygiene.

The sleeping pills market is projected to experience substantial expansion in the coming years. By 2030, its valuation is anticipated to reach $126.55 billion, exhibiting a compound annual growth rate (CAGR) of 8.0%. This anticipated growth throughout the forecast period stems from factors such as the creation of new non-benzodiazepine medications, the increasing use of melatonin and herbal sleep aids, greater penetration of online pharmacies, tailored sleep treatment initiatives, and a growing consumer demographic of older adults and adults. Key trends during this period encompass the escalating global incidence of sleep disorders, a surge in the usage of over-the-counter sleep solutions, an intensifying emphasis on individualized sleep therapies, the broadening reach of online pharmacies and e-commerce platforms, and heightened understanding regarding natural and herbal sleep supplements.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24704&type=smp

What Drivers Are Shaping The Future Growth Of The Sleeping Pills Market?

The escalating occurrence of mental health conditions is projected to drive the expansion of the sleeping pills market moving forward. Mental illness refers to a broad spectrum of psychological conditions that influence an individual’s mood, thinking, actions, and overall daily operations. The increasing incidence of mental illness is attributed to rising chronic stress levels, as prolonged stress disrupts brain function and can initiate or worsen mental health disorders. Sleeping pills assist in addressing mental illness by improving sleep quality, which is vital for emotional and cognitive stability. They contribute to reducing symptoms of anxiety and depression by fostering restful sleep and enhancing overall mental health and daily performance. For instance, in 2025, the National Alliance on Mental Illness and NextStep Solutions Behavioral Health, US-based health agencies, reported that serious mental illness (SMI) prevalence stood at around 5.44% in 2023 and remained near 5.6% of adults in 2024, signifying stability within this severe category. Thus, the growing prevalence of mental illness is propelling the growth of the sleeping pills market.

What Segment Types Make Up The Sleeping Pills Market?

The sleeping pills market covered in this report is segmented –

1) By Medication Type: Prescription Sleeping Pills, Over The Counter (OTC) Sleeping Pills

2) By Product Type: Benzodiazepines, Non Benzodiazepines

3) By Sleep Disorder: Insomnia, Sleep Disorder, Restless Leg Syndrome Narcolepsy, Sleepwalking

4) By Consumer Demographics: Age Groups, Gender, Health Conditions

5) By Distribution Channel: Retail Pharmacies, Online Pharmacies, Hospitals And Clinics, Health And Wellness Stores

Subsegments:

1) By Prescription Sleeping Pills: Benzodiazepines, Non-Benzodiazepines, Antidepressants, Antihistamines, Melatonin Receptor Agonists, Orexin Receptor Antagonists

2) By Over The Counter (OTC): Diphenhydramine, Doxylamine, Melatonin Supplements, Valerian Root

Which Market Trends Are Creating New Opportunities In The Sleeping Pills Market?

Leading companies in the sleeping pills market are concentrating on creating sophisticated formulations, including innovative drug compositions. The goal is to improve sleep quality, lessen the danger of dependence, and decrease adverse reactions. These innovative drug formulations involve crafting new medicinal compounds intended to boost effectiveness, optimize absorption, mitigate side effects, and offer more precise and user-friendly treatment alternatives. An example is the launch in October 2024 by Neurovalens, a medical device firm from the UK, of Modius Sleep. This is a medical device, cleared by the Food and Drug Administration (FDA) and prescribed by physicians, for managing chronic insomnia in adults 22 and older. The device employs gentle electrical vestibular nerve stimulation, directed at the hypothalamus and brainstem – brain regions crucial for regulating sleep and circadian rhythms. Users wear the device on their head for 30 minutes every evening, usually 1–2 hours prior to sleeping, with intensity levels that can be adjusted for personal comfort. Modius Sleep offers ease of use, portability, and can be utilized while engaging in activities like reading or watching television.

Who Are The Key Players Driving Competition In The Sleeping Pills Market?

Major companies operating in the sleeping pills market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Eisai Co Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Cipla Limited, Aurobindo Pharma Ltd. , Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Perrigo Company plc, Mallinckrodt Pharmaceuticals plc, Idorsia Pharmaceuticals Ltd, Procter & Gamble Health Limited (P&G Health), Allegiant Health

Read the full sleeping pills market report here:

https://www.thebusinessresearchcompany.com/report/sleeping-pills-global-market-report

Which Geographic Regions Are Influencing Demand In The Sleeping Pills Market?

North America was the largest region in the sleeping pills market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the sleeping pills market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Sleeping Pills Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24704&type=smp

Browse Through More Reports Similar to the Global Sleeping Pills Market 2026, By The Business Research Company

Sleep Apnea Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleep-apnea-devices-global-market-report

Sleep Tech Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleep-tech-devices-global-market-report

Sleeping Aids Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleeping-aids-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the sleeping pills market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Sleeping Pills Market in 2030?

The sleeping pills market has experienced significant expansion in recent years. Its size is forecast to grow from $85.87 billion in 2025 to $93.03 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.3%. This historical growth can be linked to the limited availability of sleep disorder treatments, the increasing prevalence of insomnia, the dominance of prescription sleeping pills, traditional pharmacy distribution channels, and low awareness about sleep hygiene.

The sleeping pills market is projected to experience substantial expansion over the coming years. By 2030, its valuation is set to reach $126.55 billion, exhibiting a compound annual growth rate (CAGR) of 8.0%. This anticipated growth during the forecast period is driven by several factors, including the introduction of innovative non-benzodiazepine medications, increased acceptance of melatonin and various herbal supplements, the growing reach of online pharmacies, tailored sleep treatment initiatives, and an enlarging base of elderly and adult consumers. Key developments anticipated during this period encompass a global surge in sleep disorder prevalence, greater use of over-the-counter sleep aids, an intensified focus on personalized sleep therapies, the proliferation of online pharmacies and e-commerce platforms, and heightened awareness regarding natural and herbal sleep supplements.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24704&type=smp

What Drivers Are Influencing Production Trends In The Sleeping Pills Market?

The escalating incidence of mental illness is projected to fuel the expansion of the sleeping pills market moving forward. Mental illness describes a broad spectrum of mental health conditions that impact an individual’s mood, thought processes, behavior, and overall capability. The rise in mental illness prevalence is attributed to increasing levels of chronic stress, as prolonged stress disrupts brain function and can trigger or intensify mental health disorders. Sleeping pills assist in managing mental illness by enhancing sleep quality, which is vital for emotional and cognitive stability. These medications help alleviate symptoms of anxiety and depression by encouraging restful sleep and improving overall mental health and daily performance. For instance, in 2025, according to the National Alliance on Mental Illness and NextStep Solutions Behavioral Health, US-based health agencies reported that serious mental illness (SMI) prevalence was about 5.44% in 2023 and remained close by 2024 at about 5.6% of adults, indicating stability in that severe category. Hence, the increasing prevalence of mental illness is a primary driver for the growth of the sleeping pills market.

Which Segment Groups Are Influencing The Sleeping Pills Market?

The sleeping pills market covered in this report is segmented –

1) By Medication Type: Prescription Sleeping Pills, Over The Counter (OTC) Sleeping Pills

2) By Product Type: Benzodiazepines, Non Benzodiazepines

3) By Sleep Disorder: Insomnia, Sleep Disorder, Restless Leg Syndrome Narcolepsy, Sleepwalking

4) By Consumer Demographics: Age Groups, Gender, Health Conditions

5) By Distribution Channel: Retail Pharmacies, Online Pharmacies, Hospitals And Clinics, Health And Wellness Stores

Subsegments:

1) By Prescription Sleeping Pills: Benzodiazepines, Non-Benzodiazepines, Antidepressants, Antihistamines, Melatonin Receptor Agonists, Orexin Receptor Antagonists

2) By Over The Counter (OTC): Diphenhydramine, Doxylamine, Melatonin Supplements, Valerian Root

Which Trends Are Shaping Activity Within The Sleeping Pills Market?

Leading entities within the sleeping pills market are concentrating on developing advanced compositions, such as novel drug formulations, with the aim of improving sleep quality, reducing the likelihood of dependency, and minimizing adverse reactions. Novel drug formulations involve the creation of new medicinal compounds designed to enhance effectiveness, improve absorption, decrease side effects, and offer more precise and patient-friendly therapeutic options. As an illustration, in October 2024, Neurovalens, a UK-based medical device company, introduced Modius Sleep. This Food and Drug Administration (FDA)-cleared, physician-prescribed medical device is specifically engineered to address chronic insomnia in adults aged 22 and older. It functions by utilizing low-level electrical vestibular nerve stimulation to target the hypothalamus and brainstem, which are critical areas for regulating sleep and circadian rhythms. The device is to be worn on the head for 30 minutes each evening, typically 1–2 hours before bedtime, and features adjustable intensity for the user’s comfort. Modius Sleep is user-friendly, portable, and can be worn while undertaking activities such as reading or watching TV.

Who Are The Major Companies Operating In The Sleeping Pills Market?

Major companies operating in the sleeping pills market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Eisai Co Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Cipla Limited, Aurobindo Pharma Ltd. , Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Perrigo Company plc, Mallinckrodt Pharmaceuticals plc, Idorsia Pharmaceuticals Ltd, Procter & Gamble Health Limited (P&G Health), Allegiant Health

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/sleeping-pills-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Sleeping Pills Market?

North America was the largest region in the sleeping pills market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the sleeping pills market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Sleeping Pills Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24704&type=smp

Browse Through More Reports Similar to the Global Sleeping Pills Market 2026, By The Business Research Company

Sleep Apnea Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleep-apnea-devices-global-market-report

Sleep Tech Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleep-tech-devices-global-market-report

Sleeping Aids Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleeping-aids-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Sleeping Pills Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The sleeping pills market size has shown substantial expansion in recent years. It is anticipated to increase from $79.21 billion in 2024 to $85.87 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 8.4%. This historical growth stems from growing awareness about sleep health, increasing stress and anxiety in daily life, influence of lifestyle changes and urbanization, increasing geriatric population, and rising research and development activities.

The sleeping pills market is anticipated to experience robust expansion in the upcoming years, projected to reach $117.31 billion by 2029 at a compound annual growth rate (CAGR) of 8.1%. This projected growth is primarily driven by factors such as increasing demand for non-addictive options, the development of personalized and targeted sleep therapies, rising investment in biotechnology, stringent regulatory approvals, and the expansion of healthcare infrastructure. Key trends anticipated during the forecast period encompass the utilization of digital biomarkers to tailor sleep medication, the integration of artificial intelligence (AI) and machine learning, breakthroughs in cannabinoid-based sleep therapeutics, nanotechnology for targeted drug delivery, and the emergence of wearable sleep monitoring devices.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24704&type=smp

What Are The Main Drivers Boosting The Sleeping Pills Industry’s Expansion?

The escalating prevalence of mental illness is projected to fuel the growth of the sleeping pills market moving forward. Mental illness encompasses a wide array of mental health conditions that impact an individual’s mood, thought processes, behavior, and general functioning. The rise in mental illness prevalence is linked to increasing levels of chronic stress, as prolonged stress can disrupt brain function and either trigger or worsen mental health disorders. Sleeping pills contribute to managing mental illness by enhancing sleep quality, which is crucial for emotional and cognitive stability. They help alleviate symptoms of anxiety and depression by facilitating restful sleep and improving overall mental well-being and daily performance. For instance, in 2022, according to the National Institute of Mental Health, a US-based federal government research agency, 59.3 million adults aged 18 and older in the United States had any mental illness (AMI), accounting for 23.1% of the total adult population. Consequently, the increasing prevalence of mental illness is a significant driver for the growth of the sleeping pills market.

What Are The Major Segment Types Covered In The Sleeping Pills Market?

The sleeping pills market covered in this report is segmented –

1) By Type: Prescription Sleeping Pills, Over The Counter (OTC) Sleeping Pills

2) By Product Type: Benzodiazepines, Non Benzodiazepines

3) By Sleep Disorder: Insomnia, Sleep Disorder, Restless Leg Syndrome Narcolepsy, Sleepwalking

4) By Consumer Demographics: Age Groups, Gender, Health Conditions

5) By Distribution Channel: Retail Pharmacies, Online Pharmacies, Hospitals And Clinics, Health And Wellness Stores

Subsegments:

1) By Prescription Sleeping Pills: Benzodiazepines, Non-Benzodiazepines, Antidepressants, Antihistamines, Melatonin Receptor Agonists, Orexin Receptor Antagonists

2) By Over The Counter (OTC): Diphenhydramine, Doxylamine, Melatonin Supplements, Valerian Root, Other Herbal Or Natural Supplements

How Are Trends Influencing The Sleeping Pills Market?

Leading companies operating in the sleeping pills market are concentrating on developing advanced compositions, such as novel drug formulations, with the goal of improving sleep quality, minimizing dependency risks, and reducing undesirable side effects. Novel drug formulations signify the creation of new medicinal compounds specifically engineered to enhance efficacy, boost absorption, diminish side effects, and offer more targeted and patient-friendly treatment approaches. For instance, in October 2024, Neurovalens, a UK-based medical device company, unveiled Modius Sleep, a Food and Drug Administration (FDA)-cleared, physician-prescribed medical device engineered to treat chronic insomnia in adults aged 22 and older. This device functions by utilizing low-level electrical vestibular nerve stimulation to target the hypothalamus and brainstem, which are critical areas for regulating sleep and circadian rhythms. Users wear the device on their head for 30 minutes each evening, typically 1–2 hours before bedtime, with customizable intensity settings for user comfort. Modius Sleep is user-friendly, portable, and can be worn while undertaking activities such as reading or watching TV.

Which Key Players Are Driving Competition In The Sleeping Pills Market?

Major companies operating in the sleeping pills market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Eisai Co Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Cipla Limited, Aurobindo Pharma Ltd. , Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Perrigo Company plc, Mallinckrodt Pharmaceuticals plc, Idorsia Pharmaceuticals Ltd, Procter & Gamble Health Limited (P&G Health), Allegiant Health

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/sleeping-pills-global-market-report

Which Geographies Are Emerging As Strong Markets For The Sleeping Pills Industry?

North America was the largest region in the sleeping pills market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the sleeping pills market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Sleeping Pills Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24704&type=smp

Browse Through More Reports Similar to the Global Sleeping Pills Market 2025, By The Business Research Company

Sleep Apnea Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/sleep-apnea-devices-global-market-report

Sleep Tech Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/sleep-tech-devices-global-market-report

Sleeping Aids Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/sleeping-aids-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Industry Valuation for the Sleeping Pills Sector?

In recent times, the market size for sleeping pills has seen robust growth. The market is expected to expand from $79.21 billion in 2024 to $85.87 billion in 2025, at a Compound Annual Growth Rate (CAGR) of 8.4%. This growth trajectory in the past is due to heightened awareness of sleep health, a rise in stress and anxiety levels brought on by everyday life, lifestyle changes and urbanization trends, a growing aged population, and an increase in research and development initiatives.

In the coming years, there is a strong anticipation for robust expansion in the sleeping pills market. The projections suggest that by 2029, the market will surge to $117.31 billion, with a compound annual growth rate (CAGR) of 8.1%. The upswing during this forecast period is expected due to the augmentation in demand for non-addictive pills, progress in bespoke and targeted sleep therapies, an upsurge in biotechnology investments, inflexible regulatory approvals, and broadening of healthcare infrastructure. The forthcoming trends within this period include the use of digital biomarkers in customizing sleep medication, the blend of artificial intelligence (AI) and machine learning, progress in cannabinoid-based sleep remedies, the employment of nanotechnology in targeted drug delivery and the emergence of wearable sleep monitoring gadgets.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24704&type=smp

What Forces Are Driving The Growth Of The Sleeping Pills Market?

The escalating occurrence of mental health disorders is predicted to fuel the expansion of the sleeping pills market in the future. Mental health disorders encompass a broad spectrum of conditions that impact an individual’s mood, thought processes, behavior, and general functionality. The growth in mental disorders is spurred by heightened levels of chronic stress, as sustained stress impairs brain performance and either initiates or intensifies mental health issues. Sleeping pills contribute to the management of mental disorders by enhancing sleep quality, which is crucial for emotional and cognitive balance. They alleviate symptoms of anxiety and depression by fostering peaceful sleep and boosting overall mental health and everyday functionality. For example, in 2022, the National Institute of Mental Health, a federal government research agency based in the US, reported that 59.3 million adults aged 18 and above in the United States suffered from any mental illness (AMI), making up 23.1% of the entire adult populace. Hence, the escalating occurrence of mental health disorders is propelling the expansion of the sleeping pills market.

How Is The Sleeping Pills Industry Segmented Across Key Parameters?

The sleeping pills market covered in this report is segmented –

1) By Type: Prescription Sleeping Pills, Over The Counter (OTC) Sleeping Pills

2) By Product Type: Benzodiazepines, Non Benzodiazepines

3) By Sleep Disorder: Insomnia, Sleep Disorder, Restless Leg Syndrome Narcolepsy, Sleepwalking

4) By Consumer Demographics: Age Groups, Gender, Health Conditions

5) By Distribution Channel: Retail Pharmacies, Online Pharmacies, Hospitals And Clinics, Health And Wellness Stores

Subsegments:

1) By Prescription Sleeping Pills: Benzodiazepines, Non-Benzodiazepines, Antidepressants, Antihistamines, Melatonin Receptor Agonists, Orexin Receptor Antagonists

2) By Over The Counter (OTC): Diphenhydramine, Doxylamine, Melatonin Supplements, Valerian Root, Other Herbal Or Natural Supplements

What Notable Trends Are Shaping The Direction Of The Sleeping Pills Market?

Leading businesses in the sleeping pills industry are concentrating their efforts on creating enhanced formulations such as innovative drug concoctions. These are intended to escalate sleep quality, lessen dependency threats, and mitigate side effects. Such innovative drug recipes hint at the invention of novel medicinal mixtures that aim to boost effectiveness, amplify absorption, decrease side effects, and offer more targeted and patient-friendly treatment alternatives. For instance, Neurovalens, a medical device entity based in the UK, unveiled Modius Sleep in October 2024. This FDA-approved, physician-prescribed medical apparatus was created specifically for managing chronic insomnia in adults aged 22 and above. It leverages low-intensity electrical vestibular nerve stimulation to target the brainstem and hypothalamus, regions that oversee sleep and circadian rhythms. This apparatus is worn on the head for half an hour each night, usually 1-2 hours preceding sleep, with an adjustable intensity according to the user’s comfort level. The Modius Sleep is user-friendly, mobile, and wearable during recreational activities such as reading or watching television.

Which Companies Currently Dominate The Competitive Landscape In The Sleeping Pills Industry?

Major companies operating in the sleeping pills market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Eisai Co Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Cipla Limited, Aurobindo Pharma Ltd. , Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Perrigo Company plc, Mallinckrodt Pharmaceuticals plc, Idorsia Pharmaceuticals Ltd, Procter & Gamble Health Limited (P&G Health), Allegiant Health

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/sleeping-pills-global-market-report

Which Geographic Regions Are Driving Demand In The Sleeping Pills Market?

North America was the largest region in the sleeping pills market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the sleeping pills market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24704&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model